NCT06480864 Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer Status RECRUITING Phase NA
NCT06467786 Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer Status RECRUITING Phase PHASE4
NCT06462105 Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer Status NOT_YET_RECRUITING Phase NA
NCT06406660 Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer Status RECRUITING Phase NA
NCT06364046 Efficacy and Safety of DEB-BACE Combined With Serplulimab in First-line Treatment of SCLC Status NOT_YET_RECRUITING Phase NA
NCT06283719 Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06257264 A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors Status RECRUITING Phase PHASE1
NCT06203210 A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT06117774 Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06095505 A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT06064500 Tarlatamab (AMG 757) Expanded Access Protocol for Advanced Small Cell Lung Cancer Status APPROVED_FOR_MARKETING Phase N/A
NCT06047379 Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis Status RECRUITING Phase PHASE1/PHASE2
NCT05983432 Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors Status RECRUITING Phase PHASE1
NCT05978284 Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma Status RECRUITING Phase PHASE1/PHASE2
NCT05924841 A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Extensive Stage Small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT05903092 MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT05889546 Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer Status RECRUITING Phase N/A
NCT05886075 A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors Status UNKNOWN Phase EARLY_PHASE1
NCT05882630 Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer Status NOT_YET_RECRUITING Phase PHASE1/PHASE2